The endotoxin-lipoprotein hypothesis

Lancet

Volumn 356, Issue 9233, 2000, Pages 930-933

  Rauchhaus, Mathias ^a,b   Coats, Andrew J S ^a   Anker, Stefan D ^a,c  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^c MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; STATIN;

ATHEROGENESIS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CORONARY RISK; HEART FAILURE; HUMAN; HYPERCHOLESTEROLEMIA; PRIORITY JOURNAL; REVIEW; TREATMENT INDICATION;

EID: 0034626121     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)02690-8     Document Type: Note

References (31)

1. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia: West of Scotland Coronary Prevention Study Group
2. Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)
3. Skin test anergy in advanced heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy
4. Low serum cholesterol levels predict high perioperative mortality in patients supported by a left-ventricular assist system
5. The effects of simvastatin on the incidence of heart failure with coronary heart disease
6. Current perspectives on statins
7. Statins do more than just lower cholesterol
8. Total serum cholesterol levels and mortality risk as a function of age: A report based on the Framingham data
9. Cholesterol as risk factor for mortality in elderly women
10. Report of the conference on low blood cholesterol: Mortality associations
11. Prevention of endotoxin-induced monokine release by human low- and high-density lipoproteins and by apolipoprotein A-I
12. Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice
13. In vivo protection against endotoxin by plasma high density lipoprotein
14. Lipoprotein(a) inhibits lipopolysaccharide-induced tumor necrosis factor alpha production by human mononuclear cells
15. Triglyceride-rich lipoproteins prevent septic death in rats
16. Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS
17. Protective effects of reconstituted high-density lipoprotein in rabbit gram-negative bacteremia models
18. Role for circulating lipoproteins in protection from endotoxin toxicity
19. Low-density lipoprotein receptor-deficient mice are protected against lethal endotoxemia and severe gram-negative infections
20. Structure and function of lipopolysaccharide binding protein
21. Tlr4: Central component of the sole mammalian LPS sensor
22. Adenosine inhibits lipopolysaccharide-induced cardiac expression of tumor necrosis factor-alpha
23. Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium
24. Apo B100-containing lipoproteins are secreted by the heart
25. Endotoxin and immune activation in chronic heart failure: A prospective cohort study
26. Effects of HMG-COA reductase inhibitors (statins) in patients with heart failure
27. Monocyte activation in congestive heart failure due to coronary artery disease and idiopathic dilated cardiomyopathy
28. Vesnarinone, a new inotropic agent, inhibits cytokine production by stimulated human blood from patients with heart failure
29. Cytokine generation capacities of monocytes are reduced in patients with severe heart failure
30. Preoperative and postoperative endotoxaemia in children with congenital heart disease
31. Low-lipid concentrations in critical illness implications for preventing and treating endotoxemia